| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/22/2006 | CN1737147A Heat shock protein 65- multiple epitope hepatitis B virus core antigen recombinant protein ú¿HSP65-HBcAgú® |
| 02/22/2006 | CN1737146A Fuse protein of specific antibody N1M1 and N2M2 and its coding gene |
| 02/22/2006 | CN1737145A Lotus polyphenol oxidase gene sequence and its uses |
| 02/22/2006 | CN1737144A Composite multiple epitope bivalent nucleic acid vaccine construction for foot-and-mouth disease |
| 02/22/2006 | CN1737143A Rice disease-resistant related gene OsDR2 |
| 02/22/2006 | CN1737142A Rice disease-resistant related gene OsDR3 |
| 02/22/2006 | CN1737141A Landrace fatness candidate gene SOCS-3 sequence and its uses |
| 02/22/2006 | CN1737140A Schizophrenia related nucleic acid sequence |
| 02/22/2006 | CN1737139A Prostate disease related gene and its coding polypeptide and its uses |
| 02/22/2006 | CN1737138A Pig ouclar muscles area character-related protein and its coding gene and uses |
| 02/22/2006 | CN1737137A Plasmid DNA large scale purification process |
| 02/22/2006 | CN1737136A Production method of animal use recombinant interferon |
| 02/22/2006 | CN1737121A Escherichia bacteria capable of generating l-amino acid and method for generating l-amino acid |
| 02/22/2006 | CN1737120A Escherichia bacteria capable of generating L-amino acid and method for generating L-amino acid |
| 02/22/2006 | CN1737119A Escherichia bacteria capable of generating l-amino acid and method for generating l-amino acid |
| 02/22/2006 | CN1737113A Novel bacillus named BARB and its uses |
| 02/22/2006 | CN1737112A Constitutive P. pastoris strain and its construction method |
| 02/22/2006 | CN1737037A Polyethylene imine nanometer gel and its uses |
| 02/22/2006 | CN1737012A Recombinant targeted infuse protein for promoting thrombocytopoiesis and its preparation method |
| 02/22/2006 | CN1737011A Lymphoma specific chimeric monoclonal antibody against HLA-DR10 |
| 02/22/2006 | CN1736482A Recombined chicken pox virus vaccine rFPV-12LSH5H9, its construction method and use |
| 02/22/2006 | CN1736481A Recombined chicken pox virus vaccine rPFV-12LSH9A, preparation process and use thereof |
| 02/22/2006 | CN1243104C Production of agartose -4, 6 |
| 02/22/2006 | CN1243099C Use and obtain of inactivating lumour CHK1 gene anticancer recombined gland virus constituent |
| 02/22/2006 | CN1243098C Paddy rice anti-reverse transcripfactor and its coding gene and application |
| 02/22/2006 | CN1243097C Human ICAM-1 extramembranous I-III domain gene expression product ,its prep. and application in radioimmunological technology |
| 02/22/2006 | CN1243096C Recombined D-hydantoin enzyme and application thereof |
| 02/22/2006 | CN1243021C Interleukin-18 binding proteins, their preparation and use |
| 02/22/2006 | CN1243020C Application of cardiokinetic hormone in liver disease |
| 02/22/2006 | CN1243018C Blood vessel generating inhibitor |
| 02/22/2006 | CN1243017C Tumor suppressor, coded protein and application thereof |
| 02/22/2006 | CN1243016C Beta tubulin of cotton fiber and its coding gene and application |
| 02/22/2006 | CN1243010C Fast DNA extracting and purifying process with nanoscale particle of aminated silica |
| 02/22/2006 | CN1242809C Applications of T-BAM (CD40L) technology in preparation of medicine to treat diseases involving smooth muscle cell |
| 02/21/2006 | US7003440 Method, system, and program for use in displaying expression phenomenon in living matters |
| 02/21/2006 | US7002063 Inbred corn line BT751-31 |
| 02/21/2006 | US7002062 Soybean cultivar 0509254 |
| 02/21/2006 | US7002060 Enzymes involved in petroselinic acid biosynthesis |
| 02/21/2006 | US7002059 introducing novel expansin gene sequences from heterologous and homologous tree species into Eucalyptus trees so as to alter expansin levels; modification of morphology of plant fibre cells; for use in paper |
| 02/21/2006 | US7002058 Transforming soybean (Glycine max) using Agrobacterium mediated transformation of a plant tissue explant and subsequent regeneration of the transformed cells into a whole plant |
| 02/21/2006 | US7002057 Thioredoxin H homologs |
| 02/21/2006 | US7002047 Biocatalytic synthesis of quinic acid and conversion to hydroquinone |
| 02/21/2006 | US7002005 Analytical detection of Staphylococcus aureus |
| 02/21/2006 | US7002003 oligonucleotide with optimal nucleotide binding sites for transcription factor; signal trandsducers and activators of transcription (STAT); treating cancer |
| 02/21/2006 | US7002001 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 02/21/2006 | US7002000 Nucleic acid encoding α chain of human IL-11 receptor |
| 02/21/2006 | US7001998 Nucleic acids encoding a chimeric glycosyltransferase |
| 02/21/2006 | US7001997 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits |
| 02/21/2006 | US7001995 Synthetic human papillomavirus genes |
| 02/21/2006 | US7001993 site-directed mutagenesis; high protease-inhibitory activity in absence of heparin |
| 02/21/2006 | US7001986 Fluorescent proteins |
| 02/21/2006 | US7001985 for controlling activity of cyclin-dependent kinases; treating cancer, immune disorders |
| 02/21/2006 | US7001980 Monoclonal antibodies directed against the G3BP protein, and uses |
| 02/21/2006 | US7001891 Biodegradable polycation composition for delivery of an anionic macromolecule |
| 02/21/2006 | US7001890 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 02/21/2006 | US7001884 polypeptide with selective amino acid substitutions; nontoxic protease inhibitors; bactericides, fungicides, viricides |
| 02/21/2006 | US7001882 Muteins of bilin-binding protein |
| 02/21/2006 | US7001772 Product and process for transformation of Thraustochytriales microorganisms |
| 02/21/2006 | US7001771 Genes encoding wheat starch synthases and uses thereof |
| 02/21/2006 | US7001770 enhancing p53-mediated apoptosis by co-administering the p53 tumor suppressor gene with a cysteine protease inhibitor; antitumor agents; synergistic immunotherapy |
| 02/21/2006 | US7001769 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 02/21/2006 | US7001768 Targeted modification of chromatin structure |
| 02/21/2006 | US7001766 Nucleotide sequences coding polypeptide for use the treatment of hypercholesterolaemia, diabetes, hypercholesterolaemia, hypoglycemia, graves disease, goiter, cushing's, addison, gastrointestinal and autoimmune diseases |
| 02/21/2006 | US7001765 immunotherapy; expression vector with foreign DNA coding for an immunostimulant protein; genetic vaccines with tumor antigens; anticarcinogenic, antitumor agents |
| 02/21/2006 | US7001764 Compositions comprising tissue specific adenoviral vectors |
| 02/21/2006 | US7001763 isolated cDNA, recombinant expression vector, cultured host cell; gene expression; antisense therapy, pharmacogenetics |
| 02/21/2006 | US7001762 Neurospora crassa (N. crassa); nucleotide sequences; vectors and host cells; silencing gene has a RNA-dependent RNA polymerase domain; use to study gene silencing as it pertains to expression of transgenes |
| 02/21/2006 | US7001761 DNA sequences comprising dystrophin minigenes and methods of use thereof |
| 02/21/2006 | US7001760 Hepatitis B virus vectors for gene therapy |
| 02/21/2006 | US7001759 Compositions and methods for delivery of genetic material |
| 02/21/2006 | US7001757 Protein |
| 02/21/2006 | US7001754 Methods and compositions for the introduction of molecules into cells |
| 02/21/2006 | US7001753 59079 and 12599, protein kinase family members and uses therefor |
| 02/21/2006 | US7001752 Murine and human kinases |
| 02/21/2006 | US7001751 PyrF gene and the utilization thereof |
| 02/21/2006 | US7001747 Where the polylinker has multiple restriction enzyme sites in place of one or more polyketide sythase (PKS) genes encoding enzymes associated with reduction; vectors, host cells; biosynthesis of B1 avermectin |
| 02/21/2006 | US7001745 Preparing a target protein with a carboxy-terminal thioester by producing a target protein fused to an intein and selectively cleaving the fusion with mercaptoethanesulfonic acid; semi-synthetic method of cytotoxic protein synthesis for example |
| 02/21/2006 | US7001744 Gene encoding an antigenic determinant of Escherichia coli is connected to a nontoxic cholera toxin A2 and B subunits (CTXA2B) gene of Vibrio cholerae; chimeric protein is useful as oral vaccine against uropathogenic E. coli with mild side effects |
| 02/21/2006 | US7001743 Nucleotide sequences coding polypeptide for use in controlling cell enlargement in plants |
| 02/21/2006 | US7001739 Isolation of proteins involved in posttranscriptional gene silencing and methods of use |
| 02/21/2006 | US7001734 Process for identifying para cation channel modulators |
| 02/21/2006 | US7001733 Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement |
| 02/21/2006 | US7001732 RIP3 associated cell cycle protein |
| 02/21/2006 | US7001731 Antibody specific for a chemokine receptor; immunoassay and kits |
| 02/21/2006 | US7001729 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 02/21/2006 | US7001728 Protein of given amino acid sequence which is the product of a gene which shows enhanced expression due to stimulation with TNF alpha; use drug screening; plays an important role in protein protein interactions; drug target |
| 02/21/2006 | US7001724 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases |
| 02/21/2006 | US7001723 Catalytic RNAs with aminoacylation activity |
| 02/21/2006 | US7001721 Nucleic acid sequence identification |
| 02/21/2006 | US7001720 Cloning of a gene mutation for parkinson's disease |
| 02/21/2006 | US7001614 Liposome complexes for increased systemic delivery |
| 02/21/2006 | US7001599 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/21/2006 | US7001597 Methods for altering fertility |
| 02/21/2006 | US7001596 vector comprises tumor specific promoter, for killing neoplastic cells |
| 02/21/2006 | US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy |
| 02/21/2006 | CA2431859C Transgenic and cloned mammals |
| 02/21/2006 | CA2216609C Production of antibodies using cre-mediated site-specific recombination |
| 02/21/2006 | CA2110401C Method for the selection of genetically transformed cells and compounds for use in the method |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/21/2006 | CA2032381C Viral agent |